Customer List
R&D Manage is a sophisticated, flexible management
tool that allows us to identify, manage, and prioritize
resources by giving us the ability to track and forecast
by project as well as by overall P&L.
-- Roche Palo Alto
Our customers use R&D Manage and R&D Time as their corporate
budgeting, forecasting and tracking solution. Each deployment
is fully integrated with local accounting and payroll systems, and,
in some cases, with purchasing and time reporting systems. Finance,
management and project leaders use R&D Manage to proactively
plan and measure the business performance of their respective areas
of responsibility.
- Roche Palo Alto, LLC.
- Cytokinetics, Inc.
- Metabolex, Inc.
- Nuvelo, Inc.
- Pharmos Corporation
- Neurogen Corporation
- Novacea, Inc.
- NPS Pharmaceuticals, Inc.
- Epix Pharmaceuticals, Inc.
- Avigen, Inc.
- Adamas Pharmaceuticals, Inc.
- Titan Pharmaceuticals, Inc.
- InterMune, Inc.
- Momenta Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals, Inc.
- SGX Pharmaceuticals, Inc.
- FivePríme Therapeutics, Inc.
- Kalypsys, Inc.
- Via Pharmaceuticals, Inc.
- Catalyst Biosciences
- Savient Pharmaceuticals
- Tercica, Inc.
- Neurobiological Technologies
- Ambrx, Inc.
- Portola Pharmaceuticals, Inc.
- Nevro Corporation
- Medivation, Inc.
- KaloBios Pharmaceuticals, Inc.
- Inviragen, Inc.
- Facet Biotech Corporation
- MacroGenics, Inc.
- Hyperion Therapeutics, Inc.
- Prognosys Biosciences
- Trius Therapeutics
- Athersys, Inc.
- Anthera Pharmaceuticals, Inc.
- NovaBay Pharmaceuticals, Inc.
- Affymax, Inc.
- VitaPath Genetics, Inc.
- ReadlD Inc.

Roche Palo Alto
discovers and develops prescription drugs in key therapeutic areas
such as diseases of the nervous system, virology, infectious diseases,
oncology, cardiovascular diseases, inflammatory and autoimmune diseases,
dermatology, metabolic disorders and respiratory diseases.
Top

Cytokinetics Inc.
Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of
novel small molecule therapeutics that modulate muscle function for the potential treatment of serious
diseases and medical conditions. Top

Metabolex, Inc.
discovers and develops new drugs for type 2 diabetes and brings
to market novel drugs with distinct and complementary modes of action,
to address the full range of defects underlying diabetes.
Top

Nuvelo, Inc.
formed by the merger of Hyseq Pharmaceuticals, Inc. and VARIAGENICS, Inc.,
is focused on the discovery and development of therapeutics that
improve life. Top

Pharmos Corporation
is a bio-pharmaceutical company focused on the discovery, development
and commercialization of therapeutics for the central and peripheral
nervous systems, and ophthalmologic, cardiovascular and inflammation-related
indications. Top

Neurogen Corporation
is a leader in both the discovery and development of new drug candidates
and in the development and integration of new drug discovery technologies,
most notably its AIDD (Accelerated Intelligent Drug Discovery) system.
Top

Novacea, Inc.
is a rapidly growing drug development company that has the exclusive
worldwide rights to the Oregon Health & Science University (OHSU)
technology for dose and a method of use of calcitriol and its analogs,
potentially providing a major breakthrough in the treatment of cancer.
Top

NPS Pharmaceuticals, Inc.
is engaged in the discovery and development of novel,
small molecule drugs and recombinant peptides that address a variety
of important diseases. Top

EPIX Pharmaceuticals, Inc.
's goal is to transform the management and diagnosis of vascular disease
through the development of targeted MRI contrast agents.
Top

Avigen, Inc.
is commited to providing physicians and their patients with
innovative therapeutics for the treatment of neurological conditions.
Top

Adamas Pharmaceuticals, Inc.
is developing superior neuroprotective medicines
for the treatment of central nervous system disorders.
Top

Titan Pharmaceuticals, Inc.
(AMEX: TTP) is a biopharmaceutical company focused on the development and commercialization
of novel treatments for central nervous system disorders, cardiovascular disease,
bone disease and other disorders.
Top

Intermune, Inc.
is a biopharmaceutical company focused on developing and commercializing
innovative therapies in pulmonology and hepatology.
Top

Momenta Pharmaceuticals, Inc.
is a biotechnology company specializing in the detailed structural analysis
and design of complex sugars for the development of improved versions of existing drugs,
the development of novel drugs, and the discovery of new biological processes.
Top

Alnylam Pharmaceuticals, Inc.
is a biopharmaceutical company developing novel therapeutics based on a breakthrough
discovery that enables the creation of a broad new class of human therapeutics.
Top

SGX Pharmaceuticals, Inc.
is a biotechnology company focused on the discovery,
development and commercialization of innovative cancer therapeutics.
Top

FivePríme Therapeutics, Inc.
is developing treatments for cancer and diabetes and multiple leads in metabolic and immunologic diseases, oncology and regenerative medicine.
Top

Kalypsys, Inc.
is developing breakthrough therapies for some of the world's most widespread diseases
including cardiovascular/metabolic diseases, pain/inflammation and oncology.
Top

Via Pharmaceuticals, Inc.
is a biotechnology company focused on the development of compounds for the
treatment of cardiovascular disease. Their drug development pipeline consists of both pre-clinical and
clinical-stage small molecule drugs that target various stages of vascular inflammation.
Top

Catalyst Biosciences
is a leading biotechnology
company focused on developing proteases as a therapeutic platform for inflammation,
cardiovascular, and angiogenesis-based disorders.
Top

Savient Pharmaceuticals, Inc.
is a specialty biopharmaceutical company engaged
in developing and distributing pharmaceutical products that target
unmet medical needs in both niche and broader markets.
Top

Tercica, Inc.
is a biopharmaceutical company working to develop and commercialize
therapeutics for growth and other endocrine disorders.
Top

Neurobiological Technologies, Inc.
is a biotechnology company engaged in the business of acquiring and developing central nervous
system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer.
Top

Ambrx, Inc.
is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis
that enables the company to genetically engineer proteins with new amino acid building blocks beyond the
common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological
properties.
Top

Portola Pharmaceuticals, Inc.
is discovering and developing novel therapeutics to meet patient needs in cardiovascular,
inflammation, and oncology indications.
Top

Nevro Corporation
is a medical device company developing novel neuromodulation therapies for multiple indications.
The company's initial focus is the development of an implantable device for the treatment of chronic pain.
Top

Medivation, Inc.
is a biopharmaceutical company with small molecule drugs in clinical development to treat three large,
unmet medical needs—Alzheimer’s disease,
Huntington’s disease and castration-resistant prostate cancer.
Top

KaloBios Pharmaceuticals, Inc.
, a U.S. based, private monoclonal company,
uses its biologic capabilities and its proprietary platform technology to develop
first-in-class human antibody therapeutics.
Top

Inviragen, Inc.
, is focused on developing life-saving vaccines to protect against emerging
infectious diseases worldwide. Inviragen's lead product is a vaccine to protect against dengue fever,
a disease that threatens 2.5 billion people across the globe.
Top

Facet Biotech Corporation
combines expertise in antibody engineering with a disciplined, biology-driven research approach.
Facet Biotech is dedicated to advancing their current pipeline of four clinical-stage products
and leveraging their research and development capabilities to identify and develop new drugs.
Top

MacroGenics, Inc.
, is focused on applying its world-class antibody capabilities to discover, develop
and deliver to patients novel biologics for the treatment of autoimmune disorders, cancer and
infectious diseases.
Top

Hyperion Therapeutics, Inc.
, is a privately held pharmaceutical company focused on the development of treatments that
address critical unmet needs in the areas of gastroenterology and hepatology. Top

Prognosys Biosciences
is an early-stage biotechnology company focusing on the promising and rapidly developing field of personalized medicine.
Prognosys carries out R&D in the area of novel assays and biomarker discovery,
and uses next-generation sequencing technologies for the analysis of complex systems.
Top

Trius Therapeutics
is a biopharmaceutical company focused on the discovery, development and commercialization
of innovative antibiotics for serious, life-threatening infections Top

Athersys, Inc.
is a biopharmaceutical company engaged in the discovery and development of therapeutic product
candidates designed to extend and enhance the quality of human life. Through the application of our
proprietary technologies, we have established a pipeline of therapeutic product development programs in
multiple disease areas. Top

Anthera Pharmaceuticals
is a biopharmaceutical company focused on developing
and commercializing products to treat serious illnesses,
including cardiovascular and autoimmune diseases. Top

NovaBay Pharmaceuticals
is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide compounds, which are novel,
synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white blood cells.
Top

Affymax
is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often
life-threatening conditions. The company's product candidate, peginesatide (formerly known as HematideT), has been investigated in Phase 3 trials
for the potential treatment of anemia associated with chronic renal failure.
Top

Vitapath Genetics, Inc.
is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease.
Its first product is a genetic test to identify risk factors that are associated with a common birth defect called Spina Bifida
and which can be safely corrected with low-risk vitamin supplementation under the care of a physician.
Top

RealD
is a leading global licensor of stereoscopic (three-dimensional), or 3D, technologies. Its extensive intellectual property portfolio enables a premium 3D viewing experience in the theater, the home and elsewhere.
Top
|